Rankings
▼
Calendar
▼
GLSI Q3 2019 Earnings Report — Greenwich LifeSciences, Inc. Revenue & Financial Results | Market Cap Arena
Greenwich LifeSciences, Inc.
GLSI
Q3 2019 Earnings
Reported September 29, 2019
Quarter Comparison
Revenue
Operating Income
EPS (Diluted)
Free Cash Flow
Metric
Q3 2019
Q2 2019
Q3 2018
QoQ Change
YoY Change
Revenue
$0
$0
—
—
—
Op. Income
-$336.0K
-$3M
—
87.1%
—
EPS (Diluted)
$-0.03
$-0.22
—
87.2%
—
Free Cash Flow
$900
$0
—
—
—
marketcaparena.com
Income Statement
Item
Amount
REVENUE
$0
Cost of Revenue
$0
GROSS PROFIT
$0
R&D Expenses
$284.5K
Selling & Marketing
$0
General & Administrative
$51.5K
SG&A Expenses
$51.5K
Other Expenses
$0
Operating Expenses
$336.0K
Cost & Expenses
$336.0K
OPERATING INCOME
-$336.0K
Interest Income
$0
Interest Expense
$0
Other Income/Expenses
$0
INCOME BEFORE TAX
-$336.0K
Income Tax Expense
$0
Net Income from Continuing Ops
-$336.0K
Net Income from Discontinued Ops
$0
Other Adjustments
$0
NET INCOME
-$336.0K
Net Income Deductions
$0
BOTTOM LINE NET INCOME
-$336.0K
D&A
$902
EBIT
-$336.0K
EBITDA
-$335.1K
EPS
-$0
EPS Diluted
-$0
marketcaparena.com
Cash Flow Statement
Item
Amount
Net Income
-$336.0K
Depreciation & Amortization
$902
Stock-Based Compensation
$0
Deferred Income Tax
$0
Other Non-Cash Items
$200.2K
Change in Working Capital
$336.0K
OPERATING CASH FLOW
$900
Capital Expenditure
$0
Acquisitions (Net)
$0
Purchases of Investments
$0
Sales/Maturities of Investments
$0
Other Investing Activities
$0
NET CASH FROM INVESTING
$0
Net Debt Issuance
$0
Common Stock Repurchased
$0
Common Dividends Paid
$0
Other Financing Activities
$0
NET CASH FROM FINANCING
$0
FREE CASH FLOW
$900
Net Change in Cash
$900
marketcaparena.com
← FY 2019
GLSI Overview
Q4 2019 →